153 related articles for article (PubMed ID: 20408337)
1. Underexpression and overexpression of Fas and Fas ligand: a double-edged sword.
Randhawa SR; Chahine BG; Lowery-Nordberg M; Cotelingam JD; Casillas AM
Ann Allergy Asthma Immunol; 2010 Apr; 104(4):286-92. PubMed ID: 20408337
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Khalili B; Bahna SL
Ann Allergy Asthma Immunol; 2006 Sep; 97(3):272-80; quiz 281-3, 320. PubMed ID: 17042130
[TBL] [Abstract][Full Text] [Related]
3. The involvement of Fas/FasL interaction in porcine circovirus type 2 and porcine reproductive and respiratory syndrome virus co-inoculation-associated lymphocyte apoptosis in vitro.
Chang HW; Jeng CR; Lin CM; Liu JJ; Chang CC; Tsai YC; Chia MY; Pang VF
Vet Microbiol; 2007 May; 122(1-2):72-82. PubMed ID: 17321702
[TBL] [Abstract][Full Text] [Related]
4. Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand.
Abe R; Shimizu T; Shibaki A; Nakamura H; Watanabe H; Shimizu H
Am J Pathol; 2003 May; 162(5):1515-20. PubMed ID: 12707034
[TBL] [Abstract][Full Text] [Related]
5. ROS-mediated p38alpha MAPK activation and ERK inactivation responsible for upregulation of Fas and FasL and autocrine Fas-mediated cell death in Taiwan cobra phospholipase A(2)-treated U937 cells.
Liu WH; Cheng YC; Chang LS
J Cell Physiol; 2009 Jun; 219(3):642-51. PubMed ID: 19180563
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Fas/Fas ligand-mediated apoptotic cell death of lymphocytes in vitro by circulating anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus.
Suzuki N; Ichino M; Mihara S; Kaneko S; Sakane T
Arthritis Rheum; 1998 Feb; 41(2):344-53. PubMed ID: 9485093
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells.
Villunger A; Egle A; Kos M; Hartmann BL; Geley S; Kofler R; Greil R
Cancer Res; 1997 Aug; 57(16):3331-4. PubMed ID: 9269989
[TBL] [Abstract][Full Text] [Related]
8. Overexpressed exogenous IL-4 And IL-10 paradoxically regulate allogenic T-cell and cardiac myocytes apoptosis through FAS/FASL pathway.
Furukawa H; Oshima K; Tung T; Cui G; Laks H; Sen L
Transplantation; 2008 Feb; 85(3):437-46. PubMed ID: 18301335
[TBL] [Abstract][Full Text] [Related]
9. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
[TBL] [Abstract][Full Text] [Related]
10. Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer.
Zhang B; Sun T; Xue L; Han X; Zhang B; Lu N; Shi Y; Tan W; Zhou Y; Zhao D; Zhang X; Guo Y; Lin D
Carcinogenesis; 2007 May; 28(5):1067-73. PubMed ID: 17183065
[TBL] [Abstract][Full Text] [Related]
11. Fas-Fas ligand-mediated apoptosis within aqueous during idiopathic acute anterior uveitis.
Dick AD; Siepmann K; Dees C; Duncan L; Broderick C; Liversidge J; Forrester JV
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2258-67. PubMed ID: 10476791
[TBL] [Abstract][Full Text] [Related]
12. Critical roles for JNK, c-Jun, and Fas/FasL-Signaling in vitamin E analog-induced apoptosis in human prostate cancer cells.
Jia L; Yu W; Wang P; Li J; Sanders BG; Kline K
Prostate; 2008 Mar; 68(4):427-41. PubMed ID: 18196534
[TBL] [Abstract][Full Text] [Related]
13. The expression of Fas/FasL and apoptosis in yak placentomes.
JiangFeng F; Jiu YS; Wen ZZ; Ben L
Anim Reprod Sci; 2011 Oct; 128(1-4):107-16. PubMed ID: 22014664
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the Fas-Fas ligand system and active caspase-3 in abnormal apoptosis in human testes with maturation arrest and Sertoli cell-only syndrome.
Kim SK; Yoon YD; Park YS; Seo JT; Kim JH
Fertil Steril; 2007 Mar; 87(3):547-53. PubMed ID: 17123522
[TBL] [Abstract][Full Text] [Related]
15. Association of Fas Ligand gene polymorphism with Stevens-Johnson syndrome.
Ueta M; Sotozono C; Inatomi T; Kojima K; Hamuro J; Kinoshita S
Br J Ophthalmol; 2008 Jul; 92(7):989-91. PubMed ID: 18577653
[TBL] [Abstract][Full Text] [Related]
16. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.
Ungefroren H; Voss M; Jansen M; Roeder C; Henne-Bruns D; Kremer B; Kalthoff H
Cancer Res; 1998 Apr; 58(8):1741-9. PubMed ID: 9563493
[TBL] [Abstract][Full Text] [Related]
17. Fas/Fas ligand on the road: an apoptotic pathway common to AIDS, autoimmunity, lymphoproliferation and transplantation.
Famularo G; Nucera E; Marcellini S; De Simone C
Med Hypotheses; 1999 Jul; 53(1):50-62. PubMed ID: 10499826
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of Fas and FasL pro-apoptotic proteins in basal cell and squamous cell carcinomas.
Wang XY; Zhang R; Lian S
Clin Exp Dermatol; 2011 Jan; 36(1):69-76. PubMed ID: 20497185
[TBL] [Abstract][Full Text] [Related]
19. ALPS: an autoimmune human lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
Puck JM; Sneller MC
Semin Immunol; 1997 Feb; 9(1):77-84. PubMed ID: 9106310
[TBL] [Abstract][Full Text] [Related]
20. Reciprocal co-expression of Fas and Fas ligand in human cholangiocarcinoma.
Pan G; Ahn EY; Chen Y; Feng G; Reddy V; Jhala NC; McDonald JM
Int J Oncol; 2007 Oct; 31(4):843-50. PubMed ID: 17786316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
